Delivery Order SPE2DR25D3004-SPE2DR26FXWB2
- Not listed
- The Defense Logistics Agency awarded a $2,033.08 firm fixed-price delivery order to AmerisourceBergen Drug Corp (parent company: Cencora, Inc.) on January 16, 2026, for the supply of Nemluvio 30 mg pens, with a completion deadline of February 9, 2026. This delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a task order under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $6,099.24 delivery order to Amerisourcebergen Drug Corp (parent company Cencora, Inc.) on January 20, 2026, for Nemluvio 30 mg pens, with a completion deadline of February 10, 2026. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a task order issued under Amerisourcebergen's substantial...
- The Defense Logistics Agency awarded a $1,929.20 delivery order to AmerisourceBergen Drug Corp for Nemluvio 30 mg pens, with an ultimate completion date of September 24, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in Conshohocken, PA 19428. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $2,033.08 to AmerisourceBergen Drug Corp for the supply of Nemluvio 30 mg pens, with an ultimate completion date of February 10, 2026. This is a firm fixed-price, non-set-aside contract with place of performance in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., a major pharmaceutical distributor that serves as a critical vendor for federal medical procurement, particularly supporting...
- The Defense Logistics Agency awarded a $6,099.24 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 8, 2026, for the supply of Nemluvio 30 mg pens, with an ultimate completion date of January 30, 2026. This contract was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., a major pharmaceutical distributor serving federal healthcare...
- The Defense Logistics Agency awarded a delivery order valued at $2,033.08 to AmerisourceBergen Drug Corp for Nemluvio 30 mg pens, with a completion date of February 11, 2026. This competitive award, issued on January 21, 2026, utilizes firm fixed-price pricing and is being performed at the awardee's corporate headquarters location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, indicating full and open competition among qualified vendors. This delivery order is...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $2,033.08 by the Defense Logistics Agency (DLA) on January 26, 2026, for the supply of Nemluvio 30 mg pens. The contract is firm fixed price with no set-aside designation and is scheduled for completion by February 17, 2026. Performance will be executed at the awardee's location in Conshohocken, Pennsylvania. This delivery order is issued under Amerisourcebergen's parent company Cencora, Inc.'s...
- The Defense Logistics Agency awarded a delivery order valued at $2,033.08 to AmerisourceBergen Drug Corp for the supply of Nemluvio 30 mg pens, with an ultimate completion date of February 20, 2026. This non-competitive delivery order employs firm fixed-price pricing and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., a major pharmaceutical distributor that serves as a critical vendor for federal...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a $7,716.80 delivery order to AmerisourceBergen Drug Corp for Nemluvio 30 mg pens, with an ultimate completion date of August 20, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the prime contractor. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $3,858.40 delivery order to AmerisourceBergen Drug Corp for Nemluvio 30 mg pens, with a completion date of September 18, 2025. This is a firm fixed-price, non-set-aside contract utilizing competitive procurement procedures. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The delivery order represents a continuation of the company's extensive federal pharmaceutical supply...
- SPE2DR25D3004Indefinite Delivery Contract
- SPE2DR25D3004-SPE2DR26FXWB2Delivery Order
The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., for Nemluvio 30 mg pens with a ceiling value of $2,033.08. This is a firm fixed-price, non-set-aside delivery order with a completion date of February 24, 2026, issued on February 2, 2026. The contract represents a task order under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement. The company's performance location is listed as Conshohocken, Pennsylvania. The broader IDC vehicle through which this delivery order was issued enables the supply of a diverse range of pharmaceutical products including specialty medications, brand-name and generic drugs, vaccines, and medical supplies to support military treatment facilities and other federal healthcare systems worldwide, including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 2/1/26 |